Ascend Capital’s Medtronic MDT Stock Holding History

Ascend Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-347,433	Closed	-$27.9M	–	207
2018 Q1	$27.9M	Buy	+347,433	New	+$28.7M	1.13%	27
2017 Q2	–	Sell	-277,568	Closed	-$22.4M	–	175
2017 Q1	$22.4M	Buy	+277,568	New	+$21.7M	1.01%	40
2014 Q3	–	Sell	-110,453	Closed	-$7.04M	–	198
2014 Q2	$7.04M	Buy	+110,453	New	+$6.71M	0.23%	112
2013 Q4	–	Sell	-79,812	Closed	-$4.25M	–	213
2013 Q3	$4.25M	Buy	+79,812	New	+$4.29M	0.16%	142

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascend Capital's MDT Position: Q2 2018 in Review

Ascend Capital sold out of Medtronic (MDT) in Q2 2018, closing a stake of 347,433 shares — an estimated $27.9M sold.

Ascend Capital first reported a position in MDT in Q3 2013 and held it in 4 quarters. The position peaked at $27.9M in Q1 2018. 1,410 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

Ascend Capital reported no remaining Medtronic position as of Q2 2018 after selling out during the quarter.
Ascend Capital sold 347,433 Medtronic shares in Q2 2018, an estimated $27.9M.
Ascend Capital first reported a position in Medtronic in Q3 2013 and held it in 4 quarters.
Ascend Capital's Medtronic position peaked at $27.9M in Q1 2018.
1,410 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on Ascend Capital's 13F filing for Q2 2018, filed 13 Aug 2018.